Simbrinza Suspension/ Drops
Product Images NDC 0065-4147

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Simbrinza (NDC 0065-4147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alcon Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8ml Carton

8ml Carton
SIMBRINZA is a sterile ophthalmic suspension that contains brinzolamide and brimonidine tartrate. It is used for the treatment of ocular hypertension and open-angle glaucoma. The suspension comes in a 10g bottle with a dosage strength of 1%/0.2%. The inactive ingredients include carbomer 974P, olopatadine HCl, sodium hydroxide, hydrochloric acid, and purified water. It is produced by Alcon Laboratories and should be stored between 12-25°C. The usual dosage should be determined by a healthcare provider.*
FDA Label Image

Brimonidine Chemical Structure (Brimonidine)

FDA Label Image

Brinzolamide Chemical Structure (Brinzolamide)

FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
This appears to be a table of data from a study involving a medication called "SIMBRINZA" and two other medications, "Brinzolamide" and "Brim." The table shows a change of 10 mmHg in pressure (presumably intraocular pressure) for the treatment group (designated by "R") compared to the control group (designated by "G"). The data is displayed over a period of 3 months, with measurements taken at various times throughout the day. However, the table provides no context or explanation for the study or its results.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
This text appears to be a table containing information related to a study on an ophthalmic medication called "SIMBRINZA." The medication contains Brinzolamide and Brimonidine. The table shows changes in millimeters of mercury (mmHg) based on various time intervals (Week 2, Week 6, and Month 3) and times of day (BAM, 10AM, 3PM, 5PM, and 8AM). The meaning and context of the variables 'o' and 'b' is not clear.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.